All Stories

  1. Functioning Pituitary Adenomas
  2. List of Contributors
  3. Étude moléculaire du gène AIP sur plus de 1400 individus atteints d’adénome hypophysaire
  4. Causes and Characteristics of Pituitary Gigantism
  5. Molecular and pathological determinants of somatostatin analogue resistance: somatotropinomas in AIP mutated and X-LAG syndrome patients
  6. The genetic causes of pituitary gigantism
  7. The clinical characteristics of X-linked acro-gigantism syndrome
  8. X-linked acro-gigantism (X-LAG): a new form of infant-onset pituitary gigantism
  9. Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference
  10. X-linked acrogigantism syndrome: clinical profile and therapeutic responses
  11. Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
  12. McCune-Albright Syndrome: A Detailed Pathological and Genetic Analysis of Disease Effects in an Adult Patient
  13. Intérêt du signal T2 des adénomes hypophysaires à GH traités par analogues de la somatostatine – premiers résultats de l’étude IRMA#2
  14. Expression of peroxisome-proliferator activated receptor [alpha] in pituitary tumours
  15. Coexistence entre adénome hypophysaire et phéochromocytome – présentation de cas
  16. FIPA : étude clinique et génétique à l’Hôpital « King Edward Memorial », Bombay (Mumbai), Inde
  17. Le Gigantisme : les résultats d’une étude clinique et génétique internationale
  18. Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations
  19. Characteristics of patients with pituitary gigantism: results of an international study
  20. The clinical characteristics of primary hyperparathyroidism (PHPT) in patients with multiple endocrine neoplasia (MEN) type 1
  21. Overview of genetic testing in patients with pituitary adenomas
  22. Osobennosti metabolizma kostnoy tkanipri sindrome mnozhestvennykh endokrinnykhneoplaziy 1 tipa